FDA head Marty Makary explains why agency is pulling safety warnings for menopause hormone therapies

The Food and Drug Administration has approved removing safety warnings from several menopausal hormone therapy products. FDA Commissioner Marty Makary joins "The Takeout" to explain what's behind the agency's decision.